Nasdaq GlobeNewswire

SDL Selects Appian for Digital Transformation

Del

 

Appian Automates and Digitizes SDL's Core Business; Streamlining Operations, Enhancing Integration, Restructuring Best Practices and Enabling Faster Decision Making

RESTON, Va., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN), a leading  Low-Code and Business Process Management  platform provider, today announced SDL selected Appian to automate and digitize its core language services business in support of the company's digital transformation strategy. Using Appian's low-code development platform in the cloud enables SDL to rapidly unify data from across systems and processes, and present them through a single intuitive interface, resulting in significant improvements in customer experience.

SDL is a leader in global content creation, management, translation and delivery. It offers companies a range of solutions to address complex content management and translation challenges, including Machine Translation, Localization, Web Content Management and provides a host of integrations with third-party applications. Appian is being used to transform these core processes in support of SDL's corporate growth strategy. Key goals of that strategy are to increase the scalability of SDL business services without increasing headcount resources, while ensuring quality of services through risk reduction and enforcement of policy-based best practices.

"Appian is focused on helping companies develop a business culture of continuous digital transformation," said Paul Maguire, Vice President, Appian. "The business landscape is changing faster than ever before and companies must remain agile and adaptable to change. We empower customers like SDL to streamline their operations, maximize their resources and perform faster than ever before. With Appian, SDL are making their business operations more intelligent by integrating analytics and automated, rules based, workflow into formal, orchestrated processes."

In the execution of SDL's digital transformation strategy, Appian is currently addressing the following needs:

  • Digitization and automation of core processes: With Appian, SDL is organizing core information, minimizing human error, reducing operational risk, and connecting core legacy applications. This provides access to the right data, information and intelligence enabling employees to spend less time on manual processes and low value touch points.
     
  • Improved Enterprise Visibility: Using Appian Records and Reports, SDL is providing clear visibility to participants across the whole process to provide greater planning and capacity management, enable information and insights to be shared quickly and effectively which will result in the ability to make informed decisions, take prompt actions and reduce costs.
     
  • Increased Productivity and Efficiency: By streamlining processes and connecting core data, employees save time in undertaking repetitive low-value tasks to focus on high-value activities.
     
  • Mobility and Security: Using the Appian Cloud, SDL can conduct business in a secure state, connecting tasks and data across multiple processes. With the ability to access data anywhere, anytime, Appian consolidates core business information for easy access across the globe.

"Appian was the right partner to help us execute our digital transformation efforts quickly and efficiently," said Azad Ootam, Chief Transformation Officer, SDL. "With Appian, we are leveraging a single, fully integrated platform for automating and managing business processes to create efficiency and streamline business operations at scale. With these improvements we have, in a particular business process, seen improvements of up to 90% in end-to-end execution time while enhancing the customer experience."

About Appian
Appian provides a leading low-code software development platform that enables organizations to rapidly develop powerful and unique applications. The applications created on Appian's platform help companies drive digital transformation and competitive differentiation. For more information, visit www.appian.com.

About SDL
SDL (LSE:SDL) is the global innovator in language translation technology, services and content management. Over the past 25 years we've helped companies deliver transformative business results by enabling powerful, nuanced digital experiences with customers around the world. Are you in the know? Find out why 78 out of the top 100 global brands work with us at SDL.com and follow us on LinkedIn, Twitter and Facebook.

For Information Contact:
Nicole Greggs
Director, Media Relations
703.260.7868
nicole.greggs@appian.com

 
 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Appian Corporation via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu(TM) Vaccine18.12.2017 22:56Pressemelding

RSV F Vaccine informational analysis completed in fourth quarter of 2017 RSV F Vaccine interim analysis expected mid-2018 with approximately 4,600 enrollees Filing of RSV F Vaccine BLA anticipated by late 2019 NanoFlu Vaccine data package to be completed and released in February 2018 GAITHERSBURG, Md., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the Phase 3 trial of its RSV F protein recombinant nanoparticle vaccine (RSV F Vaccine) for infants via maternal immunization will continue. Novavax also provided an update on its nanoparticle influenza vaccine candidate with proprietary Matrix-M(TM) adjuvant (NanoFlu(TM)). RSV F Vaccine for Infants via Maternal Immunization "Novavax has completed an informational analysis of our Phase 3 trial of the RSV F Vaccine for infants via maternal immunization using threshold criteria for a commercial product. As a result,

SD-WAN Market Leader, Aryaka, Releases First EMEA Edition of its State of SD-WAN Connectivity Report18.12.2017 15:06Pressemelding

Research finds up to 20x cloud and SaaS application performance improvements when connecting via private network-based SD-WANs versus the public Internet LONDON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, has released its first EMEA Edition of the State of SD-WAN Connectivity report that analyses the performance of SD-WAN deployments over the Internet as compared with those delivered over global private networks. The report highlights specific application response times between various European, Middle East, Asia-Pacific and Americas locations, as well as key factors that impact the performance of cloud and SaaS applications. This research helps IT leaders in Europe, Middle East and Africa (EMEA) to evaluate the best underlying connectivity for their SD-WAN deployments to ensure fast, reliable and consistent performance for all on-premises, cloud and SaaS applications, including voice, video, and data. The report reveals significant dif

Navigators to Acquire Belgian Specialty Insurer18.12.2017 07:30Pressemelding

STAMFORD, CT, December 18, 2017 - The Navigators Group, Inc. (NASDAQ:NAVG) today announced that it has entered into a share purchase agreement for the purchase of all of the shares of Assurances Continentales - Continentale Verzekeringen NV ("ASCO") and Bracht, Deckers & Mackelbert NV ("BDM").  ASCO and BDM are both based in Antwerp, Belgium. The proposed acquisition is part of Navigators' strategy of expanding its well-established specialty insurance expertise to more brokers and insureds across Europe. ASCO is a specialty insurance company offering marine and property and casualty insurance. BDM is an insurance underwriting agency that underwrites risk coverage in niche markets on behalf of ASCO and a number of major international insurers. Additionally, as part of the transaction, Navigators will acquire all the shares of Canal Re SA, a Luxembourg reinsurance company that is a wholly-owned subsidiary of ASCO.  The acquisition reinforces Navigators' presence in the European Un

Oxford Immunotec and QIAGEN N.V. Settle Patent Infringement Lawsuit15.12.2017 22:04Pressemelding

Agreement includes payment of $27.5 million to Oxford, royalty-free license to QIAGEN and dismissal of all pending litigation OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Ltd. (Nasdaq:OXFD) and QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt Stock Exchange:QIA) announced today that they have reached a settlement in the lawsuit in the U.S. District Court for the District of Massachusetts in Boston (15-cv-13124-NMG) alleging patent infringement in relation to QIAGEN's QuantiFERON®-TB Gold and QuantiFERON®-TB Gold Plus products. Under terms of the agreement, all pending claims between Oxford and QIAGEN and the co-defendants have been resolved. As part of the settlement, Oxford has granted QIAGEN a royalty-free, non-exclusive license that extends to all current and future customers of QuantiFERON-TB Gold and QuantiFERON-TB Gold Plus in exchange for a one-time, lump-sum payment of $27.5 million.  The settlement includes general

Algeco Scotsman Announces Acquisition of Iron Horse Ranch15.12.2017 21:32Pressemelding

BALTIMORE, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Algeco/Scotsman Holding S.à r.l. (together with its subsidiaries, the "Algeco Group") today announced the successful closing of the acquisition by the Algeco Group's subsidiary, Target Logistics Management, LLC ("Target Logistics"), of Iron Horse Ranch from funds managed by TDR Capital LLP ("TDR"). The acquisition solidifies Target Logistics' position as the single largest provider of turnkey workforce housing in the U.S., including a network of eight lodges and 2,119 beds in the Permian Basin. With the acquisition, Target Logistics' Permian Basin lodge network now includes Texas lodges in Pecos, Mentone, San Angelo and two in Odessa, along with two lodges in Carlsbad and Lovington, New Mexico. Additionally, Target Logistics adds Eagle Ford lodges in Cameron and Yorktown, Texas. Diarmuid Cummins, CEO Algeco Scotsman: "Today we announce the completion of the second of two strategic acquisitions which we flagged earlier

Elemica Named to Food Logistics Top 100 List15.12.2017 13:55Pressemelding

11th Consecutive Win for Delivering Value Across Clients' Supply Chains WAYNE, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Elemica, the leading  Business Network for the process industries, announces the company has been named to Food Logistics magazine's FL100+ Award for the 11th year. The FL100+ list recognizes leading software and technology providers in the food and beverage industry.  Elemica was chosen for helping agricultural and food ingredient businesses conduct more efficient and error free commerce across their community of suppliers, customers and logistics providers - delivering value through lower operating expenses and working capital costs. "We are honored to be included for the past eleven years on the Food Logistics FL100+ list for helping companies improve efficiencies and generate value from their supply chains," said John Blyzinskyj, CEO of Elemica. "Automating business processes, enabling end-to-end visibility, and providing a platform for

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom